Field safety notices: guidance for manufacturers

AI Summary

The UK Medicines and Healthcare products Regulatory Agency (MHRA) issued this guidance to clarify manufacturer obligations regarding Field Safety Corrective Actions (FSCA) and Field Safety Notices (FSN) under the UK Medical Devices Regulations 2002. The document outlines how manufacturers must manage risks for devices already on the market to prevent serious incidents. Key regulatory issues identified by the MHRA include poor traceability, the use of excessive technical jargon that obscures safety messages, and the failure to include critical data such as batch numbers or clear user instructions in safety communications. Manufacturers are required to maintain rigorous records using Unique Device Identifiers (UDI) and establish clear data-sharing agreements with distributors to ensure end-users can be reached during a recall. Standard procedures require manufacturers to submit draft notices to the MHRA via the online MORE portal for review five days prior to distribution, except in urgent safety emergencies. Required actions for compliance include using official templates, providing factual explanations of device malfunctions, and issuing clear instructions for device quarantine or modification. Furthermore, manufacturers must include an acknowledgment form to track response rates and submit regular status reports to the MHRA until the corrective action is resolved. Failure to provide clear or timely information may result in the MHRA issuing its own public health alerts or initiating legal compliance actions.